2024-03-06 20:25:03 ET
Inovio Pharmaceuticals, Inc. (INO)
Q4 2023 Earnings Conference Call
March 06, 2024 04:30 PM ET
Company Participants
Thomas Hong - Manager of Investor Relations
Jacqueline Shea - President and Chief Executive Officer
Michael Sumner - Chief Medical Officer
Mark Twyman - Chief Commercial Officer
Peter Kies - Chief Financial Officer
Conference Call Participants
Hartaj Singh - Oppenheimer Company
Roy Buchanan - Citizens
Yi Chen - H.C. Wainwright
Presentation
Operator
Good afternoon, ladies and gentlemen and welcome to the INOVIO Fourth Quarter and Year-End 2023 Financial Results Conference Call. At this time all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Wednesday, March 06, 2024.
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Thomas Hong
Good afternoon, and thank you for joining the INOVIO 2023 fourth quarter and full-year financial results conference call.
Joining me on today's call are Dr. Jacque Shea, President and CEO; Dr. Michael Sumner, Chief Medical Officer; Mark Twyman, Chief Commercial Officer; and Peter Kies, Chief Financial Officer.
Today's call will review our corporate and financial information for the quarter and full-year ended December 31, 2023, as well as provide a general business update. Following prepared remarks, we will conduct a question-and-answer segment.
During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop INOVIO's DNA medicines platform, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic matters. All of these statements are based on the beliefs and expectations of management as of today....
Read the full article on Seeking Alpha
For further details see:
Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript